NCT00461032View on ClinicalTrials.gov

Montelukast Back to School Asthma Study (0476-340)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,162

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Asthma
Interventions
DRUG

montelukast

montelukast 5 mg tablet Once a day (QD) for 8 weeks

DRUG

Comparator: Placebo

Placebo to montelukast QD for 8 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00461032 - Montelukast Back to School Asthma Study (0476-340) | Biotech Hunter | Biotech Hunter